94,252
Participants
Start Date
February 14, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
October 31, 2025
Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP)
IPTi will be administered as full therapeutic courses of SP alongside routine EPI immunisations at defined intervals corresponding to vaccination schedules - usually at 10 weeks, 14 weeks, and 9 months of age - to infants living in project districts. Additional doses of IPTi will be administered at 6, 12, and 15 or 18 months of age, coinciding with vitamin A administration and measles booster immunisation. The number of doses of IPTi a child will receive will depend of the EPI schedule in the country, with a maximum of six doses in the first two years of life.
Fundaçao Manhiça, Manhiça
College of Medicine & Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown
University of Lomé, Lomé
Institut de Recherche pour le Developpement
OTHER_GOV
Centro de Investigação em Saúde de Manhiça
OTHER
Medicines for Malaria Venture
OTHER
University of Lomé (UL), Togo
UNKNOWN
University of Sierra Leone
OTHER
Barcelona Institute for Global Health
OTHER